Literature DB >> 10643786

Hyperglycemia triggers massive neutrophil deposition in brain following transient ischemia in rats.

B Lin1, M D Ginsberg, R Busto, L Li.   

Abstract

Myeloperoxidase (MPO) immunohistochemistry was used to ascertain the role of polymorphonuclear leukocytes in hyperglycemia-induced accentuation of brain injury after transient ischemia. Rats received 12.5 min of normothermic global cerebral ischemia by bilateral carotid occlusion plus hypotension. Hyperglycemia was induced before ischemia by intraperitoneal dextrose administration. Quantitative MPO immunohistochemistry was performed at 24 h and 3 days postischemia. Brains of normoglycemic-ischemic animals contained almost no MPO activity. By contrast, striking numbers of MPO-positive cells were present in brains studied 24 h after hyperglycemic ischemia, both within pial and parenchymal vessels and within the parenchyma. MPO deposition tended to subside at 3 days. These results indicate that hyperglycemia triggers the early, massive deposition of neutrophils in the postischemic brain--an event that may contribute to exacerbation of injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10643786     DOI: 10.1016/s0304-3940(99)00889-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Uric Acid Is Protective After Cerebral Ischemia/Reperfusion in Hyperglycemic Mice.

Authors:  Carles Justicia; Angélica Salas-Perdomo; Isabel Pérez-de-Puig; Lisette H Deddens; Geralda A F van Tilborg; Clara Castellví; Rick M Dijkhuizen; Ángel Chamorro; Anna M Planas
Journal:  Transl Stroke Res       Date:  2016-12-15       Impact factor: 6.829

2.  Effects of glycemic regulation on chronic postischemia pain.

Authors:  Marie-Christine Ross-Huot; André Laferrière; Cho Min Gi; Mina Khorashadi; Thomas Schricker; Terence J Coderre
Journal:  Anesthesiology       Date:  2011-09       Impact factor: 7.892

3.  Tenoxicam exerts a neuroprotective action after cerebral ischemia in rats.

Authors:  Rita I M Galvão; João P L Diógenes; Graziela C L Maia; Emídio A S Filho; Silvânia M M Vasconcelos; Dalgimar B de Menezes; Geanne M A Cunha; Glauce S B Viana
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

4.  Hyperglycemia reduces functional expression of astrocytic Kir4.1 channels and glial glutamate uptake.

Authors:  D E Rivera-Aponte; M P Méndez-González; A F Rivera-Pagán; Y V Kucheryavykh; L Y Kucheryavykh; S N Skatchkov; M J Eaton
Journal:  Neuroscience       Date:  2015-09-25       Impact factor: 3.590

Review 5.  Cerebral edema in children with diabetic ketoacidosis.

Authors:  N Glaser
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

6.  Acute rosiglitazone treatment during reperfusion after hyperglycemic stroke is neuroprotective not vascular protective.

Authors:  Sara Morales Palomares; Julie G Sweet; Marilyn J Cipolla
Journal:  Transl Stroke Res       Date:  2012-05-15       Impact factor: 6.829

7.  Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism.

Authors:  Nicole Glaser; Catherine Ngo; Steven Anderson; Natalie Yuen; Alexandra Trifu; Martha O'Donnell
Journal:  Diabetes       Date:  2012-04-12       Impact factor: 9.461

Review 8.  Insulin: a wonder drug in the critically ill?

Authors:  A B Johan Groeneveld; Albertus Beishuizen; Frans C Visser
Journal:  Crit Care       Date:  2002-02-08       Impact factor: 9.097

Review 9.  Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation.

Authors:  Giolanda Varvarousi; Antonia Stefaniotou; Dimitrios Varvaroussis; Theodoros Xanthos
Journal:  Cardiovasc Drugs Ther       Date:  2014-10       Impact factor: 3.727

10.  Hyperglycemia as a Risk Factor of Ischemic Stroke.

Authors:  Ziyan Zhang; Jingqi Yan; Honglian Shi
Journal:  J Drug Metab Toxicol       Date:  2013-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.